Related Experiment Video
Updated: Aug 26, 2025

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
Role of CXCR3 in fibrotic tissue responses
1Departments of Pathology, Bioengineering, and Computational & Systems Biology, and McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA; R&D Service, Pittsburgh VA Health System, Pittsburgh, PA 15213, USA.
Abstract:
Development of fibrosis leads to end stage diseases that defy treatments across all organs. This ensues as chronic inflammation is not dampened by physiologic processes that issue in the resolution phase of wound healing. Thus, these conditions can be considered diseases of "failure to heal". In the absence of broadly viable treatments, it is proposed to examine key switches in wound healing resolution to seek insights into novel approaches. Signaling through the GPCR CXCR3 has been shown to be one such critical player in this physiologic transition that limits and even reverses early fibrosis. As such, a number of investigators and early stage technology companies have posited that triggering this signaling network would limit fibrosis. While there are some conflicting results, a consensus is emerging that pharmacologic interventions that promote signaling through this pathway represent innovative ways to limit fibrotic diseases.
Insights
Fibrosis, a disease of "failure to heal," may be treated by targeting the GPCR CXCR3 pathway. Promoting this signaling network shows promise in limiting and reversing fibrosis, offering novel therapeutic strategies.
Area of Science:
- Cellular biology
- Immunology
- Pathology
Background:
- Fibrosis, characterized by chronic inflammation and a failure in wound healing resolution, leads to end-stage organ diseases.
- Current treatments for fibrotic diseases are limited, necessitating the exploration of novel therapeutic targets.
Purpose of the Study:
- To investigate key molecular switches in wound healing resolution for novel anti-fibrotic approaches.
- To examine the role of G protein-coupled receptor (GPCR) CXCR3 signaling in limiting or reversing fibrosis.
Main Methods:
- Review of existing literature on wound healing, fibrosis, and GPCR signaling.
- Analysis of studies investigating the impact of CXCR3 pathway activation on fibrotic processes.
Main Results:
- The GPCR CXCR3 pathway is identified as a critical regulator in the transition from inflammation to healing.
- Evidence suggests that promoting CXCR3 signaling can limit and potentially reverse early-stage fibrosis.
Conclusions:
- Targeting the CXCR3 pathway represents a promising, innovative strategy for developing new treatments for fibrotic diseases.
- Pharmacologic interventions aimed at enhancing CXCR3 signaling warrant further investigation for their anti-fibrotic potential.
More Related Videos
Related Concept Videos
Introduction to Fibroblasts
Intracellular Signaling Affects Focal Adhesions
Some...
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...
Extracellular Matrix

